The Latest Cardiac and Vascular News
ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Myriam J. Curet, M.D., to its Board of Directors. Dr. Curet currently serves as Executive Vice President and Chief Medical Officer for Intuitive […]
July 26, 2021 Second-quarter highlights Group sales increased to EUR 4.2 billion, with 9% comparable sales growth Comparable order intake decreased 15%, with strong double-digit growth in the Diagnosis & Treatment businesses and a decline in the Connected Care businesses on the back of COVID-19-related 167% growth in Q2 2020 […]
– Biospectal raises $ 4.3 million in seed funds led by digital health investor SeedLink The remote monitoring and patient biosensing company will use the investment to scale its OptiBP ™ blood pressure measurement and monitoring product and operations worldwide; Renowned Interventional Cardiologist and Inventor, Dr. Fred St. Goar , MD, and Tim Juergens , of […]
Seasoned medical device executive prepares for commercialization of innovative heart failure therapy SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead […]
LEXEO obtains exclusive rights to three investigational AAV-mediated gene therapy programs for rare cardiac disorders, all of which have no existing disease-modifying treatments available Strategic acquisition expands LEXEO’s rare cardiac gene therapy pipeline making it one of the most extensive in the field NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) […]
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure via Transcatheter Ventricular Restoration (TCVR), today announced the appointment of Raymond W. Cohen as the Company’s chairman and named Rinda K. Sama and Andrew G. Hinson to its board of directors. Mr. Cohen […]
MEXICO CITY, July 20, 2021 /PRNewswire/ — m8 Pharmaceuticals and Pharmanovia have signed an exclusive licensing agreement for a portfolio of several brands for Mexico & Brazil. This portfolio is comprised of well-known established brands for the treatment of cardiovascular, nervous system, and rheumatological illnesses. The main goal of the partnership is to continue to strengthen […]
Advancing a pipeline of first-in-class Controlled Metabolic Accelerators (CMAs) to harness the body’s natural processes to improve cellular metabolism and treat the underlying causes of poor metabolic health and cardiovascular disease Initial programs to focus on type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), heart failure with preserved ejection […]
Alliance to Focus on Improving the Quality, Access, and Value of Cardiovascular Disease Care in Northeast Florida NEW YORK, July 20, 2021 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care delivery platform, today announced a partnership with First Coast Heart & Vascular Center, P.C., the largest independent cardiovascular disease physician group in Northeast […]
Beverly Huss to join Board of Directors SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced it has closed an $80 million equity financing. Sands Capital, Sio Capital and an undisclosed strategic investor joined all existing investors in this financing. The […]
